Author:
Nallagundla Sumalatha,Patnala Srinivas,Kanfer Isadore
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmaceutical Science,Agronomy and Crop Science,Ecology,Aquatic Science,General Medicine,Ecology, Evolution, Behavior and Systematics
Reference15 articles.
1. FDA, CDER. Guidance for Industry. Topical dermatologic corticosteroids: in vivo bioequivalence. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070234.pdf(1995 ). Accessed 9 Jan 2013.
2. Lionberger RA. FDA critical path initiatives: opportunities for generic drug development. AAPS J. 2008;10(1):103–9.
3. Chang RK, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. AAPS J. 2013;15(1):41–52.
4. Draft Guidance on Acyclovir. 2012. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm296733.pdf . Accessed 22 Jan 2013.
5. Raney S, Lehman P, Franz T. 30th Anniversary of the Franz cell finite dose model: the crystal ball of topical drug development. Drug Deliv Technol. 2008;7(8):32–7.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献